Showing results (201-210 of 1,074) with videos related to

Sort By:
Pageof 108
Therapeutic Advances in Neurological Disorders|May 16, 2024
Effectiveness and safety of telitacicept for refractory generalized myasthenia gravis: a retrospective studyJing Lin, Yue Li, Mengcui Gui, et al.
Therapeutic Advances in Neurological Disorders|May 29, 2024
TAURUS-MS II: real-world use of teriflunomide in Germany and changes in treatment patterns over timeBoris-Alexander Kallmann, Georg Zu Eulenburg, Jennifer S Kullmann, et al.
Therapeutic Advances in Neurological Disorders|April 15, 2024
Treatment algorithms of relapsing multiple sclerosis: an exploration based on the available disease-modifying therapies in ChinaJun Guo, Jiayong Wu, Lihua Wang, et al.
Therapeutic Advances in Neurological Disorders|April 19, 2024
Long-term safety and efficacy of zilucoplan in patients with generalized myasthenia gravis: interim analysis of the RAISE-XT open-label extension studyJames F Howard, Saskia Bresch, Constantine Farmakidis, et al.
Therapeutic Advances in Neurological Disorders|April 19, 2024
A review of Bruton's tyrosine kinase inhibitors in multiple sclerosisLaura Airas, Robert A Bermel, Tanuja Chitnis, et al.
Therapeutic Advances in Neurological Disorders|February 9, 2026
A corona-like distribution and patchy pattern of cerebellar infarcts identify patients with giant cell arteritisCarolin Beuker, Jan-Kolja Strecker, Veith Jungmann, et al.
Therapeutic Advances in Neurological Disorders|December 9, 2025
From diagnosis to treatment: patterns in disease-modifying therapy initiation in multiple sclerosisStefania Iaquinto, Mina Stanikić, Enriqueta Vallejo-Yagüe, et al.
Therapeutic Advances in Neurological Disorders|December 15, 2025
Cellular and humoral vaccination response under immunotherapies-German consensus on vaccination strategies in neurological autoimmune diseasesMuriel Schraad, Mathias Mäurer, Anke Salmen, et al.
Therapeutic Advances in Neurological Disorders|November 17, 2025
Smoking and multiple sclerosis: development and feasibility study of a MS-specific smoking cessation interventionAlex M Keller, Daniel Kotz, Claudia H Marck, et al.
Therapeutic Advances in Neurological Disorders|December 23, 2024
Chronic active lesions in multiple sclerosis: classification, terminology, and clinical significanceAssunta Dal-Bianco, Jiwon Oh, Pascal Sati, et al.
Pageof 108